Short Interest in NeueHealth, Inc. (NYSE:NEUE) Declines By 54.0%

NeueHealth, Inc. (NYSE:NEUE) was the target of a significant drop in short interest in January. As of January 15th, there was short interest totalling 9,700 shares, a drop of 54.0% from the December 31st total of 21,100 shares. Currently, 0.8% of the company’s stock are short sold. Based on an average trading volume of 34,400 shares, the short-interest ratio is presently 0.3 days.

Insider Buying and Selling

In other news, CEO George Lawrence Mikan III sold 31,798 shares of NeueHealth stock in a transaction that occurred on Monday, January 6th. The shares were sold at an average price of $7.33, for a total value of $233,079.34. Following the transaction, the chief executive officer now owns 146,539 shares of the company’s stock, valued at $1,074,130.87. This trade represents a 17.83 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, CFO Jay Matushak sold 4,970 shares of the business’s stock in a transaction on Monday, January 6th. The stock was sold at an average price of $7.33, for a total transaction of $36,430.10. Following the completion of the sale, the chief financial officer now owns 17,747 shares of the company’s stock, valued at $130,085.51. The trade was a 21.88 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 58,658 shares of company stock worth $377,034. Corporate insiders own 64.30% of the company’s stock.

Hedge Funds Weigh In On NeueHealth

An institutional investor recently bought a new position in NeueHealth stock. Partners Group Holding AG acquired a new stake in NeueHealth, Inc. (NYSE:NEUE) during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund acquired 88,645 shares of the company’s stock, valued at approximately $463,000. Partners Group Holding AG owned about 1.07% of NeueHealth at the end of the most recent reporting period. Institutional investors and hedge funds own 63.88% of the company’s stock.

Analyst Upgrades and Downgrades

Separately, Royal Bank of Canada cut their price objective on NeueHealth from $8.00 to $7.00 and set a “sector perform” rating for the company in a research report on Monday, December 9th.

NeueHealth Stock Up 0.1 %

NeueHealth stock traded up $0.01 during trading hours on Thursday, hitting $7.35. The stock had a trading volume of 9,486 shares, compared to its average volume of 36,459. The company has a 50-day moving average of $6.22 and a two-hundred day moving average of $5.62. The company has a market cap of $60.86 million, a PE ratio of -0.14 and a beta of 0.57. NeueHealth has a fifty-two week low of $3.79 and a fifty-two week high of $11.85.

NeueHealth (NYSE:NEUE) last announced its earnings results on Thursday, November 7th. The company reported ($6.78) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($2.72) by ($4.06). NeueHealth had a negative return on equity of 6.40% and a negative net margin of 36.28%. The firm had revenue of $232.93 million for the quarter, compared to analyst estimates of $230.21 million. During the same quarter last year, the business earned ($8.31) EPS. As a group, analysts forecast that NeueHealth will post -9.13 EPS for the current fiscal year.

NeueHealth Company Profile

NeueHealth, Inc, a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics.